Clinical trials
Completed trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,712 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 17 |
| 2001 | 37 |
| 2002 | 43 |
| 2003 | 68 |
| 2004 | 98 |
| 2005 | 100 |
| 2006 | 134 |
| 2007 | 126 |
| 2008 | 150 |
| 2009 | 170 |
| 2010 | 142 |
| 2011 | 159 |
| 2012 | 138 |
| 2013 | 151 |
| 2014 | 135 |
| 2015 | 146 |
| 2016 | 132 |
| 2017 | 138 |
| 2018 | 140 |
| 2019 | 96 |
| 2020 | 92 |
| 2021 | 82 |
| 2022 | 71 |
| 2023 | 60 |
| 2024 | 21 |
| 2025 | 10 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,712 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Helsinki University Central Hospital | 144 |
| Turku University Hospital | 109 |
| GlaxoSmithKline | 106 |
| Boehringer Ingelheim | 92 |
| Novartis Pharmaceuticals | 91 |
| Tampere University Hospital | 89 |
| Sanofi | 86 |
| Hoffmann-La Roche | 83 |
| Pfizer | 82 |
| AstraZeneca | 75 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 118 |
| Diabetes Mellitus | 77 |
| Prostatic Neoplasms | 61 |
| Obesity | 52 |
| Atrial Fibrillation | 44 |
| Pulmonary Disease, Chronic Obstructive | 44 |
| Arthritis, Rheumatoid | 43 |
| Breast Neoplasms | 43 |
| Diabetes Mellitus, Type 1 | 43 |
| Major Depressive Disorder | 41 |
Trials
Showing 26 to 50 of 2,712. Each trial links to its page on Pharma Observatory.
2,612 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.